Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03537586Active, not recruiting
Open-label, single-arm trial, sponsored by NYU Langone Health. Primary endpoints: Platelet Activity measured by the Index of Microcirculatory Resistance (IMR) at 12 months and Measure of Inflammation measured by the Index of Microcirculatory Resistance (IMR) at 12 months. Started Jun 2018; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03537586.